↓ Skip to main content

The Role of EGFR Family Inhibitors in Muscle Invasive Bladder Cancer: A Review of Clinical Data and Molecular Evidence

Overview of attention for article published in The Journal of Urology, January 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of EGFR Family Inhibitors in Muscle Invasive Bladder Cancer: A Review of Clinical Data and Molecular Evidence
Published in
The Journal of Urology, January 2015
DOI 10.1016/j.juro.2014.07.121
Pubmed ID
Authors

Benjamin A. Mooso, Ruth L. Vinall, Maria Mudryj, Stanley A. Yap, Ralph W. deVere White, Paramita M. Ghosh

Abstract

Conventional platinum based chemotherapy for advanced urothelial carcinoma is plagued by common resistance to this regimen. Several studies implicate the EGFR family of RTKs in urothelial carcinoma progression and chemoresistance. Many groups have investigated the effects of inhibitors of this family in patients with urothelial carcinoma. This review focuses on the underlying molecular pathways that lead to urothelial carcinoma resistance to EGFR family inhibitors.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Uruguay 1 3%
Unknown 38 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 23%
Student > Master 7 18%
Researcher 7 18%
Student > Bachelor 5 13%
Student > Postgraduate 3 8%
Other 8 21%
Readers by discipline Count As %
Medicine and Dentistry 16 41%
Agricultural and Biological Sciences 11 28%
Biochemistry, Genetics and Molecular Biology 7 18%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Unspecified 1 3%
Other 2 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2014.
All research outputs
#11,396,917
of 12,819,898 outputs
Outputs from The Journal of Urology
#11,109
of 12,524 outputs
Outputs of similar age
#238,007
of 292,772 outputs
Outputs of similar age from The Journal of Urology
#191
of 273 outputs
Altmetric has tracked 12,819,898 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,524 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,772 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.